• miR-18a–ALOXE3 Axis Regulates Ferroptosis in Glioblastoma

  2026-04-20

  This study uncovers how the microRNA miR-18a directly suppresses ALOXE3, reducing ferroptosis and enhancing migration in glioblastoma cells. The findings highlight the miR-18a/ALOXE3 pathway as a critical regulator of both cell death and tumor invasiveness, offering a potential new direction for targeted glioblastoma therapies.

• Forsythoside E: Mechanistic Insights and Protocol Precision

  2026-04-20

  Explore the advanced molecular mechanisms of Forsythoside E, a potent pyruvate kinase M2 (PKM2) inhibitor, with practical guidance on assay setup, dosing, and real-world applications. This article uniquely integrates breakthrough findings on STAT3 pathway modulation, setting a new standard for sepsis-induced liver injury research.

• Cy3 Goat Anti-Human IgG (H+L) Antibody in Advanced Immunoass

  2026-04-19

  Harness the Cy3 Goat Anti-Human IgG (H+L) Antibody for robust immunofluorescence, IHC, flow cytometry, and ELISA workflows. Discover optimized protocols, troubleshooting strategies, and translational insights inspired by leading-edge orthopoxvirus research.

• L-Ornithine in Urea Cycle Research: Advanced Workflows & Ins

  2026-04-18

  L-Ornithine, as supplied by APExBIO, empowers precise studies of urea cycle intermediates and ammonia detoxification pathways. This guide translates recent mechanistic findings into actionable protocols and troubleshooting strategies for metabolic and neurotoxicity research.

• Alfuzosin HCl Protocols: Optimizing α1 Adrenoceptor Antagoni

  2026-04-17

  Alfuzosin HCl, a selective α1 adrenoceptor antagonist, empowers precise modeling of lower urinary tract smooth muscle relaxation and BPH pathology. This guide dissects advanced workflows, troubleshooting, and protocol parameters, enabling reproducible, high-fidelity urinary tract research with APExBIO’s rigorously characterized Alfuzosin Hydrochloride.

• Dacarbazine (SKU A2197): Reliable Solutions for Cancer Assay

  2026-04-16

  Discover how Dacarbazine (SKU A2197) provides reproducible, data-backed solutions for cell viability, proliferation, and cytotoxicity assays in cancer research. This scenario-driven guide addresses real laboratory challenges, emphasizing practical workflow improvements and vendor reliability for biomedical researchers.

• Applied Use of EdU Flow Cytometry Assay Kits (Cy3) in Cell C

  2026-04-15

  EdU Flow Cytometry Assay Kits (Cy3) empower researchers with denaturation-free, multiplexed S-phase detection for high-throughput cell proliferation and genotoxicity testing. This article translates the latest mechanistic findings from bladder cancer research into practical assay strategies, with stepwise workflow optimizations and troubleshooting tips to maximize reproducibility and data quality.

• Stattic and STAT3: Strategic Leverage in Translational Oncol

  2026-04-14

  Explore how APExBIO’s Stattic uniquely empowers translational cancer researchers to dissect STAT3 signaling, optimize radiosensitization, and address the evolving interplay between tumor biology and the microbiome. This thought-leadership article synthesizes mechanistic insight, robust experimental validation, and strategic guidance—framing Stattic as both a technical asset and a catalyst for next-generation oncology breakthroughs.

• Cell Cycle Assay Kit: Precision Analysis of Cell Cycle Phase

  2026-04-13

  The Cell Cycle Assay Kit (K2263) from APExBIO empowers researchers to dissect cell cycle phases and apoptosis with high specificity via PI-based flow cytometry. Its robust performance is validated in advanced cancer research, including mechanistic studies of ALK-positive anaplastic large cell lymphoma.

• Thiazovivin (A5506) in Stem Cell Reprogramming and Survival

  2026-04-12

  Thiazovivin is a ROCK inhibitor designed to enhance induced pluripotent stem cell generation and improve human embryonic stem cell survival, especially after dissociation events like trypsinization. It is not intended for diagnostic or therapeutic applications and should not be used outside validated research workflows.

• Calpain Inhibitor I, ALLN: Practical Guidance for Lab Resear

  2026-04-12

  Calpain Inhibitor I, ALLN is a potent inhibitor of calpain and cathepsin proteases, enabling precise modulation of apoptosis and inflammation pathways in cell and animal models. It is particularly suited for apoptosis assays and ischemia-reperfusion injury models where selective protease inhibition is required. Use is limited to research contexts; do not apply for diagnostic or therapeutic purposes.

• VE-822 ATR Inhibitor: Workflow Solutions for DDR in PDAC Res

  2026-04-11

  VE-822 empowers researchers to dissect DNA damage response mechanisms and boost chemoradiotherapy sensitization, especially in pancreatic ductal adenocarcinoma (PDAC) models. This article delivers protocol insights, troubleshooting strategies, and cross-validates VE-822’s unique value in applied cancer research workflows.

• Phos binding reagent (Phosbind) acrylamide: Protocol and Wor

  2026-04-11

  Phos binding reagent (Phosbind) acrylamide provides a phosphate-binding approach for distinguishing phosphorylated from non-phosphorylated proteins during SDS-PAGE, eliminating the need for phospho-specific antibodies. This reagent is best suited for protein phosphorylation studies in the 30–130 kDa range but is not intended for targets outside this molecular weight or for analyses requiring direct antibody validation.

• Alfuzosin Hydrochloride (SKU A5173): Scenario-Driven Solu...

  2026-04-10

  This authoritative article explores real-world laboratory scenarios where Alfuzosin Hydrochloride (SKU A5173) addresses common challenges in benign prostatic hyperplasia (BPH) and cell-based assay research. By grounding best practices in data-backed guidance and referencing APExBIO’s high-purity formulation, we provide biomedical researchers and lab technicians with practical strategies for reproducibility, sensitivity, and workflow efficiency.

• Alfuzosin Hydrochloride: Advanced Quantification & Mechan...

  2026-04-09

  Explore the multifaceted role of Alfuzosin Hydrochloride as a selective α1 adrenoceptor antagonist in benign prostatic hyperplasia (BPH) research. This article uniquely bridges mechanistic pharmacology with state-of-the-art spectroscopic quantification, delivering deeper insights for advanced urinary tract research.

407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page